$RVSN Balance Sheet | Understand Stock

$RVSN

$3.09 -$0.08 (2.68%) Close

Financial Statements

In millions of USD, except per-share amounts

	Q4 FY2025 As of Dec 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021
ASSETS
Current assets
Cash and cash equivalents
Restricted cash
Deferred expenses
Accounts receivable
Inventories
Other current assets
Total current assets
Operating lease - right of use asset
Fixed assets, net
Total non current assets
TOTAL ASSETS
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities
Trade accounts payable
Current operating lease liability
Other accounts payable
Total current liabilities
Non-current operating lease liability
TOTAL LIABILITIES
Preferred A shares, NIS 0.01 par value; Authorized 100,000 shares; Issued and outstanding: No shares as at December 31, 2022 and 51,282 shares as of December 31, 2021;
Shareholders’ equity
Ordinary shares, no par value (*); Authorized: 100,000,000 shares as of December 31, 2025, and 2024; Issued and outstanding: 2,014,263 and 1,264,757 shares as of December 31, 2025, and 2024
Additional paid in capital
Accumulated deficit
Total shareholders’ equity (deficit)
Total shareholders’ equity
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

Comments